0000810084-13-000002.txt : 20130128 0000810084-13-000002.hdr.sgml : 20130128 20130128202222 ACCESSION NUMBER: 0000810084-13-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130128 FILED AS OF DATE: 20130128 DATE AS OF CHANGE: 20130128 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOJECT MEDICAL TECHNOLOGIES INC CENTRAL INDEX KEY: 0000810084 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 931099680 STATE OF INCORPORATION: OR FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20245 SW 95TH AVENUE CITY: TUALATIN STATE: OR ZIP: 97062 BUSINESS PHONE: 5036928001 MAIL ADDRESS: STREET 1: 20245 SW 95TH AVENUE CITY: TUALATIN STATE: OR ZIP: 97062 FORMER COMPANY: FORMER CONFORMED NAME: BIOJECT MEDICAL SYSTEMS LTD DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FLYNN EDWARD L CENTRAL INDEX KEY: 0001031599 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15360 FILM NUMBER: 13553328 MAIL ADDRESS: STREET 1: 211 SOMERVILLE ROAD RTE 202N CITY: BEDMINISTER STATE: NJ ZIP: 07921 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2013-01-28 0 0000810084 BIOJECT MEDICAL TECHNOLOGIES INC BJCT 0001031599 FLYNN EDWARD L 7180 SW SANDBURG STREET SUITE 100 TIGARD OR 97223 1 0 0 0 Warrant to Purchase Common Stock 0.19 2011-12-29 4 P 0 26316 0 A 2011-12-29 2014-06-28 BJCT Common Stock 26316 52632 D Warrant to Purchase Common Stock 0.19 2013-01-24 4 D 0 52632 0 D 2013-01-24 2013-01-24 BJCT Common Stock 52632 0 D Series H Convertible Preferred Stock 0.035 2013-01-24 4 P 0 3794857 0.035 A 2013-01-24 BJCT Common Stock 3794857 5072557 D Cancellation of Warrants pursuant to Convertible Debt conversion into 13,282 Series H Preferred Stock. No expiration date. Holdings: 7,842 shares of Series F Preferred Stock convertible into 784,200 shares of Common Stock; 4,935 shares of Series G Preferred Stock convertible into 493,500 shares of Common Stock; 13,282 shares of Series H Preferred Stock convertible into 3,794,857 shares of Common Stock. //Christine M. Farrell Attorney-in-Fact for Edward L.Flynn// 2013-01-28